Telehealth & Digital Health

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.

Everest Medicines bets big on MT1013, a novel dual-action drug poised to transform treatment for millions with chronic kidney disease complications.

With a new CIO bringing decades of clinical and business expertise, PayForward is betting that a patient-first approach can redefine health plan solutions.

A landmark acquisition aims to fix trial diversity and access by moving research from far-off labs into your neighborhood doctor's office. Here's why it matters.

Access earns its fourth Best in KLAS award for data archiving, a win that underscores deep customer trust and the critical role of smart data management.

With multiple Best in KLAS awards, Bluesight cements its leadership in patient safety and data security. Here's why hospitals trust their solutions.

Beyond Cancer is set to reveal early human trial data for its novel nitric oxide therapy, a move that could expand its parent company into oncology.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

Following promising early results, RESTEM's Restem-L cell therapy enters a pivotal Phase 2/3 trial, aiming to transform treatment for IIM patients.

A new partnership brings acute end-of-life care into a residential setting, allowing Austin seniors to receive critical support without leaving home.

A new partnership shows how data-driven onsite health centers are slashing hospital bills and improving patient outcomes, offering a new playbook for employers.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Industrial giant AMETEK acquires LKC Technologies, aiming to revolutionize eye care with portable diagnostic devices for early disease detection.

A New Mexico health system is betting on a full-scale AI rollout to reduce doctor burnout, improve patient care, and boost its bottom line.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

A landmark Medicare decision doubles payment for contrast-enhanced ultrasound, positioning the safer, cheaper alternative to challenge CT and MRI dominance.

Death rates fall, but a new report reveals rising incidence and stark inequities. Can new drugs and AI reshape the future for all patients?